Berg J, Fellier H, Christoph T, Grarup J, Stimmeder D. 1999. The analgesic NSAID lornoxicam inhibits cyclooxygenase (COX)-1/-2, inducible nitric oxide synthase (iNOS), and the formation of interleukin (IL)-6 in vitro Inflammation Research, 48, 369-379 Boboev A, Hasanov A, Yotova L, Hasanov H. 2012. Antioxidant activity of peptides obtained from wheat and cottonseed proteins. Bulgarian Journal of Agricultural Science, 18, 103-111 Bombardieri S, Cattani P, Ciabattoni G, Dimunno O, Pasero G, Patrono C, Pinca E, Pugliese F. 1981. The synovial prostaglandin system in chronic inflammatory arthritis- differential-effects of steroidal and non-steroidal anti-inflammatory drugs. British Journal of Pharmacology, 73, 893-901 Bjarnason I, Price A B, Zanelli G, Smethurst P, Burke M, Gumpel J M, Levi A J. 1988. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology, 94, 1070-1074 Carai M A M, Colombo G, Gessa G L, Yalamanchili R, Basavarajppa B S, Hungund B L. 2006. Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice. British Journal of Pharmacology, 148, 1043-1050 Charlier C, Michaux C. 2003. Dual inhibition of cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5- LOX) as a new strategy to provide safer non-steroidal anti-inflammatory drugs European Journal of Medicinal Chemistry, 38, 645-659 Colucci R, Fornai M, Antonioli L, Ghisu N, Tuccori M, Blandizzi C, del Tacca M. 2009. Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment. Digestive and Liver Disease, 41, 395-405 Fairbanks V, Klee G G. 1994. Biochemical Aspects of Haematology, Tietz Textbook of Clinical Chemistry. Saunders WB, Philadelphia. Fichna J, Gach K, Perlikowska R, Cravezic A, Bonnet J J, do- Rego J C, Janecka A, Storr M A. 2010. Novel endomorphin analogues with antagonist activity at the mu-opioid receptor in the gastrointestinal tract. Regulatory Peptides, 162, 109-114 Finlayson A J. 1964. Compositions of some peptides produced by enzymic hydrolysis of wheat gliadin. Canadian Journal of Biochemistry and Physiology, 42, 1133-1140 Fukudome S, Yoshikawa M. 1992. Opioid-peptides derived from wheat gluten - their isolation and characterization. FEBS Letters, 296, 107-111 Gerstenfeld LC, Thiede M, Seibert K, Mielke C, Phippard D, Svagr B, Cullinane D, Einhorn T A. 2003. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti- inflammatory drugs Journal of Orthopaedic Research, 21, 670-675 Henry D, Lim L L Y, Rodriguez L A G, Gutthann S P, Carson J L, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries J T. 1996. Variability in risk of gastrointestinal complications with individual non-steroidal anti- inflammatory drugs: Results of a collaborative meta- analysis. British Medical Journal, 312, 1563-1566 Ho A, Lievore A, Patierno S, Kohlmeier SE, Tonini M, Sternini C. 2003. Neurochemically distinct classes of myenteric neurons express the mu-opioid receptor in the guinea pig ileum. Journal of Comparative Neurology, 458, 404-411 Huebner F R, Lieberman K W, Rubino R P, Wall J S. 1984. Demonstration of high opioid-like activity in isolated peptides from wheat gluten hydrolysates. Peptides, 5, 1139-1147 Maity P, Bindu S, Dey S, Goyal M, Alam A, Pal C, Mitra K, Bandyopadhyay U. 2009. Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa a novel role of mitochondrial aconitase oxidation. Journal of Biological Chemistry, 284, 3058-3068 Matsui T, Li C H, Osajima Y. 1999. Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. Journal of Peptide Science, 5, 289-297 Matsui T, Li C H, Tanaka T, Maki T, Osajima Y, Matsumoto K. 2000. Depressor effect of wheat germ hydrolysate and its novel angiotensin I-converting enzyme inhibitory peptide, Ile-Val-Tyr, and the metabolism in rat and human plasma. Biological & Pharmaceutical Bulletin, 23, 427-431 Miao J F, Zhang J Q, Zheng L H, Yu X M, Zhu W, Zou S X. 2012. Taurine attenuates Streptococcus uberis-induced mastitis in rats by increasing T regulatory cells. Amino Acids, 42, 2417-2428 Migliore A, Granata M, Tormenta S, Lagana B, Piscitelli P, Bizzi E, Massafra U, Alimonti A, Maggi C, de Chiara R, Iannessi F, Sanfilippo A, Sotera R, Scapato P, Carducci S, Persod P, Denaro S, Camminiti M, Pagano MG, Bagnato G, et al. 2011. Hip viscosupplementation under ultra-sound guidance riduces NSAID consumption in symptomatic hip osteoarthritis patients in a long follow-up. Data from italian registry. European Review for Medical and Pharmacological Sciences, 15, 25-34 Mizuno K, Yamamoto S, Lands W E M. 1982. Effects of non-steroidal anti-inflammatory drugs on fatty-acid cyclooxygenase and prostaglandin hydroperoxidase activities activities. Prostaglandins, 23, 743-757 Motoi H, Kodama T. 2003. Isolation and characterization of angiotensin I-converting enzyme inhibitory peptides from wheat gliadin hydrolysate. Nahrung-Food, 47, 354-358 Mu M, Sun M J. 2012. Sweet potato protein hydrolysates: Antioxidant activity and protective effects on oxidative DNA damage. International Journal of Food Science and Technology, 47, 2304-2310. |